摘要
Osteoarthritis (OA) is the most common chronic joint disease characterized, for which there are no available therapies being able to modify the progression of OA and prevent long-term disability. Critical roles of G-protein coupled receptors (GPCRs) have been established in OA cartilage degeneration, subchondral bone sclerosis and chronic pain. In this review, we describe the pathophysiological processes targeted by GPCRs in OA, along with related preclinical model and/or clinical trial data. We review examples of GPCRs which may offer attractive therapeutic strategies for OA, including receptors for cannabinoids, hormones, prostaglandins, fatty acids, adenosines, chemokines, and discuss the main challenges for developing these therapies.
学科与关键词
关键词
osteoarthritisG protein-coupled receptorsclinical trialscartilage degradationOA pain
- The proton-activated G protein-coupled receptor GPR4 regulates the development of osteoarthritis via modulating CXCL12/CXCR7 signalingLi, Rong; Guan, Zijing; Bi, Shuyan; Wang, Fanhua; He, Liang; Niu, Xin; You, Yu; Liu, Yuwei; Ding, Yi; Siwko, Stefan; Wang, Ning; Zhang, Ziming*; Jin, Yunyun*; Luo, Jian*Cell Death & Disease, 2022, 13(2): 152.被引 11
- GPRC5B protects osteoarthritis by regulation of autophagy signalingHe, Liang; Xu, Ziwei; Niu, Xin; Li, Rong; Wang, Fanhua; You, Yu; Gao, Jingduo; Zhao, Lei; Shah, Karan M.; Fan, Jian*; Liu, Mingyao*; Luo, Jian*Acta Pharmaceutica Sinica B, 2023, 13(7): 2976-2989.
- New Trends in Pharmacological Treatments for OsteoarthritisCai, Xiaoyan; Yuan, Shiwen; Zeng, Yanting; Wang, Cuicui; Yu, Na*; Ding, Changhai*Frontiers in Pharmacology, 2021, 12: 645842.被引 43
